Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-Label, Uncontrolled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Activity of Zilucoplan in Pediatric Study Participants From 2 to Less Than 18 Years of Age With Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis

NCT06055959 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT06055959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06055959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-Label, Uncontrolled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Activity of Zilucoplan in Pediatric Study Participants From 2 to Less Than 18 Years of Age With Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis
Lead sponsor
UCB Biopharma SRL
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 16, 2024
Completion date
December 25, 2026
Enrollment
8 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

generalized myasthenia gravis